5.1. Analysis.
Comparison 5: Serious adverse events: parallel‐group trials and first‐period cross‐over trials, Outcome 1: Proportions of participants with serious adverse events (SAE)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.